Monday Mar 31
LabCorp Announces Changes to Board of Directors
Laboratory Corporation of America Holdings today announced that Drs. Arthur H. Rubenstein and M. Keith Weikel will retire from the Board at the conclusion of their current term on May 14, 2014 pursuant to the Board's mandatory retirement policy and Wendy E. Lane has also informed the Board of Directors of her decision to retire from the Board at ... (more)
LabCorp Announces Appointment of Chief Financial Officer
Laboratory Corporation of America Holdings today announced the appointment of Glenn A. Eisenberg as Executive Vice President and Chief Financial Officer, effective June 16, 2014 .
Press release distribution, EDGAR filing, XBRL, regulatory filings
More than 200 potential EV fast charging sites identified through partners... )--RTI Surgical announced today that the company received approval to CE mark Fortivaa Porcine Dermis and will begin distribution throughout Europe.
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
Contingent cash interest, which the Company has determined to be approximately $1.56 per Note, will be payable to holders of the Zero Coupon Notes as of the record date, which is August 27, 2014.
LabCorp is Scheduled to Present at the Barclays Capital 2014 Global Healthcare Conference
Laboratory Corporation of America Holdings today announced that David P. King, Chairman and Chief Executive Officer, is scheduled to speak at the Barclays Capital 2014 Global Healthcare Conference in Miami Beach, FL.